Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Hemp Product Industry ‘Dying On Vine’ Without Lawful Use Legislation Or Enforcement Guidance

Apr 07 2022

• By Malcolm Spicer

• Source: Alamy

Related Content

VMS Market Regulation Gets Targeted Funding In US FDA Budget; OTC Switches Get Question

Mar 16 2022

US Cannabis Legalization Cultivated By House Has Thorny Forecast For Harvest In Senate

Apr 04 2022

Making Hemp Lawful As Dietary Ingredient In US Could Be More Than Marketers Bargain For

Apr 07 2022

Biden Administration Pause On Pending Trump-Era Rules Stalls FDA Cannabinoids Guidance Progress

Jan 27 2021

Additional Topics

International United States US States Cannabidiol CBD Dietary Supplements FDA Business Strategies Commercial Compliance Consumer Cosmetics Drug Approval Standards Drug Safety Guidance Documents Ingredients Legislation Manufacturing OTC Drugs Policy Politics Regulation

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window